1887

Abstract

Introduction:

Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, multidrug-resistant (MDR) pathogens, are increasingly implicated in nosocomial outbreaksworldwide, particularly in neonatal intensive care units (NICUs). Proteus mirabilis is an uncommon nosocomial pathogen causing sepsis in neonates.

Case Presentation:

We report an outbreak of ESBL-positive MDR P. mirabilis sepsis involving five babies within 10 days in a NICU, which was promptly detected and managed. The aim of this study was to characterize the molecular mechanism of resistance to third-generation cephalosporins (3GCs) in the bacteria. Surveillance cultures were collected from health-care personnel (hand swabs, urine) and the surrounding patient-care environment. Ribotyping was performed to determine the clonality of the strain. Thirteen P. mirabilis were recovered from the blood cultures of the five babies and surveillance cultures. Twelve isolates were positive for the VEB-1 ESBL type, and were susceptible only to ciprofloxacin and carbapenems. There was an unusual phenotypic synergy observed between the 3GCs and imipenem/cefoxitin. The source of infection was traced to a contaminated multidose vial. The outbreak was associated with a high mortality (80 %). A change of empirical antibiotic policy to ciprofloxacin, with strict infection control measures, brought the outbreak to an abrupt end.

Conclusion:

This is believed to be the first report of a nosocomial outbreak of VEB-1 ESBL-producing P. mirabilis sepsis in neonates from India. The present report of infection due to VEB-1-producing P. mirabilis, an uncommon pathogen for an epidemic in a neonatal unit, highlights the growing significance of such Gram-negative bacteria as a cause of infections in newborns. Epidemic spread in a neonatal unit of an ESBL-producing Proteus species, which also had an intrinsically reduced susceptibility to imipenem, and resistance to colistin and tigecycline, can be a threatening situation and can result in high neonatal mortality unless recognized and controlled in a timely manner.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005056
2016-08-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/3/4/jmmcr005056.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005056&mimeType=html&fmt=ahah

References

  1. Al-Agamy M. H. , Shibl A. M. , Tawfik A. F. , Elkhizzi N. A. , Livermore D. M. . ( 2012;). Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia. . J Chemother 24: 97–100. [CrossRef] [PubMed]
    [Google Scholar]
  2. Ayan M. , Kuzucu C. , Durmaz R. , Aktas E. , Cizmeci Z. . ( 2003;). Analysis of three outbreaks due to Klebsiella species in a neonatal intensive care unit. . Infect Control Hosp Epidemiol 24: 495–500. [CrossRef] [PubMed]
    [Google Scholar]
  3. Becker A. H. . ( 1962;). Infection due to Proteus mirabilis in newborn nursery. . Am J Dis Child 104: 355–359. [CrossRef] [PubMed]
    [Google Scholar]
  4. Bhattacharjee A. , Sen M. R. , Prakash P. , Gaur A. , Anupurba S. . ( 2008;). Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital. . Indian J Med Microbiol 26: 356–360.[PubMed] [CrossRef]
    [Google Scholar]
  5. Bradford P. A. . ( 2001;). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. . Clin Microbiol Rev 14: 933–951. [CrossRef] [PubMed]
    [Google Scholar]
  6. CLSI ( 2012;). Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement M100-S22 . . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  7. Diekema D. J. , Pfaller M. A. , Jones R. N. , Doern G. V. , Kugler K. C. , Beach M. L. , Sader H. S. . ( 2000;). Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. . Internat J Antimicrob Agents 13: 257–271. [CrossRef]
    [Google Scholar]
  8. Endimiani A. , Luzzaro F. , Brigante G. , Perilli M. , Lombardi G. , Amicosante G. , Rossolini G. M. , Toniolo A. . ( 2005;). Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases. . Antimicrob Agents Chemother 49: 2598–2605. [CrossRef] [PubMed]
    [Google Scholar]
  9. Fluit A. C. , Jones M. E. , Schmitz F. J. , Acar J. , Gupta R. , Verhoef J. . ( 2000;). Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program 1997 and 1998. . Clin Infect Dis 30: 454–460.[CrossRef]
    [Google Scholar]
  10. Gastmeier P. , Loui A. , Stamm-Balderjahn S. , Hansen S. , Zuschneid I. , Sohr D. , Behnke M. , Obladen M. , Vonberg R. P. , Rüden H. . ( 2007;). Outbreaks in neonatal intensive care units - they are not like others. . Am J Infect Control 35: 172–176. [CrossRef] [PubMed]
    [Google Scholar]
  11. Girlich D. , Poirel L. , Leelaporn A. , Karim A. , Tribuddharat C. , Fennewald M. , Nordmann P. . ( 2001;). Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. . J Clin Microbiol 39: 175–182. [CrossRef] [PubMed]
    [Google Scholar]
  12. Girlich D. , Naas T. , Leelaporn A. , Poirel L. , Fennewald M. , Nordmann P. . ( 2002;). Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. . Clin Infect Dis 34: 603–611. [CrossRef] [PubMed]
    [Google Scholar]
  13. Jiang X. , Ni Y. , Jiang Y. , Yuan F. , Han L. , Li M. , Liu H. , Yang L. , Lu Y. . ( 2005;). Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China. . J Clin Microbiol 43: 826–831. [CrossRef] [PubMed]
    [Google Scholar]
  14. Johnson J. R. . ( 2011;). Extended-spectrum β-lactamase-producing Escherichia coli in neonatal care unit. . Emerg Infect Dis 17: 1153–1154. [CrossRef] [PubMed]
    [Google Scholar]
  15. Kim J. Y. , Park Y. J. , Kim S. I. , Kang M. W. , Lee S. O. , Lee K. Y. . ( 2004;). Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital. . J Antimicrob Chemother 54: 1144–1147. [CrossRef] [PubMed]
    [Google Scholar]
  16. Lahlaoui H. , Poirel L. , Moussa M. B. , Ferjani M. , Omrane B. , Nordmann P. . ( 2011;). Nosocomial dissemination of extended-spectrum β-lactamase VEB-1a-producing Providencia stuartii isolates in a Tunisian hospital. . Eur J Clin Microbiol Infect Dis 30: 1267–1270. [CrossRef] [PubMed]
    [Google Scholar]
  17. Livermore D. M. , Canton R. , Gniadkowski M. , Nordmann P. , Rossolini G. M. , Arlet G. , Ayala J. , Coque T. M. , Kern-Zdanowicz I. et al. ( 2007;). CTX-M: changing the face of ESBLs in Europe. . J Antimicrob Chemother 59: 165–174. [CrossRef] [PubMed]
    [Google Scholar]
  18. Naas T. , Benaoudia F. , Massuard S. , Nordmann P. . ( 2000;). Integron-located VEB-1 extended-spectrum beta-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. . J Antimicrob Chemother 46: 703–711. [CrossRef] [PubMed]
    [Google Scholar]
  19. Naas T. , Mikami Y. , Imai T. , Poirel L. , Nordmann P. . ( 2001;). Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. . J Bacteriol 183: 235–249. [CrossRef] [PubMed]
    [Google Scholar]
  20. Naas T. , Bogaerts P. , Bauraing C. , Degheldre Y. , Glupczynski Y. , Nordmann P. . ( 2006a;). Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. . J Antimicrob Chemother 58: 178–182. [CrossRef] [PubMed]
    [Google Scholar]
  21. Naas T. , Coignard B. , Carbonne A. , Blanckaert K. , Bajolet O. , Bernet C. , Verdeil X. , Astagneau P. , Desenclos J.-C. et al. ( 2006b;). VEB-1 extended-spectrum β-lactamase–producing Acinetobacter baumannii, France. . Emerg Infect Dis 12: 1214–1222. [CrossRef]
    [Google Scholar]
  22. Park S. Y. , Parker R. H. . ( 1986;). Review of imipenem. . Infect Control 7: 333–337.[PubMed] [CrossRef]
    [Google Scholar]
  23. Pasterán F. , Rapoport M. , Petroni A. , Faccone D. , Corso A. , Galas M. , Vázquez M. , Procopio A. , Tokumoto M. , Cagnoni V. . ( 2006;). Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. . Antimicrob Agents Chemother 50: 3222–3224. [CrossRef] [PubMed]
    [Google Scholar]
  24. Paterson D. L. , Bonomo R. A. . ( 2005;). Extended-spectrum beta-lactamases: a clinical update. . Clin Microbiol Rev 18: 657–686. [CrossRef] [PubMed]
    [Google Scholar]
  25. Poirel L. , Naas T. , Guibert M. , Chaibi E. B. , Labia R. , Nordmann P. . ( 1999;). Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. . Antimicrob Agents Chemother 43: 573–581.[PubMed]
    [Google Scholar]
  26. Poirel L. , Rotimi V. O. , Mokaddas E. M. , Karim A. , Nordmann P. . ( 2001;). VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait. . Emerg Infect Dis 7: 468–470. [CrossRef] [PubMed]
    [Google Scholar]
  27. Poirel L. , Menuteau O. , Agoli N. , Cattoen C. , Nordmann P. . ( 2003;). Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. . J Clin Microbiol 41: 3542–3547. [CrossRef] [PubMed]
    [Google Scholar]
  28. Roy S. , Gaind R. , Chellani H. , Mohanty S. , Datta S. , Singh A. K. , Basu S. . ( 2013;). Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae and Escherichia coli harbouring blaCTX-M-15. . Indian J Med Res 137: 791–799.[PubMed]
    [Google Scholar]
  29. Sehgal R. , Gaind R. , Chellani H. , Agarwal P. . ( 2007;). Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. . Ann Trop Paediatr 27: 45–54. [CrossRef] [PubMed]
    [Google Scholar]
  30. Tschudin-Sutter S. , Frei R. , Battegay M. , Hoesli I. , Widmer A. F. . ( 2010;). Extended spectrum beta-lactamase-producing Escherichia coli in neonatal care unit. . Emerg Infect Dis 16: 1758–1760. [CrossRef] [PubMed]
    [Google Scholar]
  31. Velasco C. , Rodríguez-Baño J. , García L. , Díaz P. , Lupión C. , Durán L. , Pascual A. . ( 2009;). Eradication of an extensive outbreak in a neonatal unit caused by two sequential Klebsiella pneumoniae clones harbouring related plasmids encoding an extended-spectrum beta-lactamase. . J Hosp Infect 73: 157–163. [CrossRef] [PubMed]
    [Google Scholar]
  32. Waters V. , Larson E. , Wu F. , San Gabriel P. , Haas J. , Cimiotti J. , Della-Latta P. , Saiman L. . ( 2004;). Molecular epidemiology of gram-negative bacilli from infected neonates and health care workers' hands in neonatal intensive care units. . Clin Infect Dis 38: 1682–1687. [CrossRef] [PubMed]
    [Google Scholar]
  33. Woodford N. , Zhang J. , Kaufmann M. E. , Yarde S. , Tomas M. M. , Faris C. , Vardhan M. S. , Dawson S. , Cotterill S. L. , Livermore D. M. . ( 2008;). Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom. . J Antimicrob Chemother 62: 1265–1268. [CrossRef] [PubMed]
    [Google Scholar]
  34. Zaidi A. K. , Huskins W. C. , Thaver D. , Bhutta Z. A. , Abbas Z. , Goldmann D. A. . ( 2005;). Hospital-acquired neonatal infections in developing countries. . Lancet 365: 1175–1188. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005056
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005056
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error